❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ News archive ❭

Digital Public Defence Apr. 26, 2021 12:15 Maxi-Lu Böschen

Maxi-Lu Böschen
Maxi-Lu Böschen

MSc Maxi-Lu Böschen from the Experimental Immunotherapy Group headed by Johanna Olweus will be defending her thesis Towards new T cell receptor-based cancer immunotherapy for the degree of PhD (Philosophiae Doctor).

Time and place: Apr. 26, 2021 12:15 PM, Zoom
 

Links:

Read complete announcement from UiO home page

Maxi-Lu Böschen

The Experimental Immunotherapy Group, headed by Johanna Olweus

 
Scroll to top

Home Cancer Medicine Institute for Cancer Research

  • Dept. of Cancer Genetics
  • Dept. of Cancer Immunology
  • Dept. of Molecular Cell Biology
  • Dept. of Molecular Oncology
  • Dept. of Radiation Biology
  • Dept. of Tumor Biology
  • Dept. of Core Facilities
  • Institute employees
  • Dept./group overview
  • Publications
  • Institute administration
  • Annual reports
  • Imaging facilities
  • Institute seminars
  • Vacant positions
  • News archive
  • Scientific Advisory Board
  • ehåndbok/HES procedures

Recent publications

From major journals, first or last author from the Institute for Cancer Research

Eggebø MS, Heinzelbecker J, Palashati H, Chandler N, Tran TT, Li Y, Yang W, Laos M, Blaas I, Rustad EH, Bollineni RC, Delic-Sarac M, Lund-Johansen F, Nielsen MM, Olweus J (2025)
TCR-engineered T cells targeting a shared β-catenin mutation eradicate solid tumors
Nat Immunol (in press)
DOI 10.1038/s41590-025-02252-1, PubMed 40866620

Ullern A, Holm K, Andresen NK, Røssevold AH, Bang C, Naume B, Hov JR, Kyte JA (2025)
Gut microbiota diversity is prognostic in metastatic hormone receptor-positive breast cancer patients receiving chemotherapy and immunotherapy
Mol Oncol (in press)
DOI 10.1002/1878-0261.70117, PubMed 40852937

Foldvari Z, Brennan MS, Titov A, Jacobsen SEW, Olweus J (2025)
Targeting the roots of myeloid malignancies with T cell receptors
Nat Rev Cancer (in press)
DOI 10.1038/s41568-025-00857-0, PubMed 40841587

More selected publications

Most recent publications

Sagini K, Selvarajah M, Romero S, Bassols-Citores E, Martin-Gracia B, Ramirez-Garrastacho M, Rise F, Endzeliņš E, Sadovska L, Skorinkina D, Boguševiča M, Cešeiko R, Čampa M, Klavina A, Linē A, Llorente A (2025)
The Redox Enzyme Thioredoxin Is Increased in Plasma Extracellular Vesicles From Endurance-Trained Females in Response to Acute Exercise
FASEB J, 39 (16), e70927
DOI 10.1096/fj.202500678R, PubMed 40810354

Switlyk MD, Dale E, Tafjord S, Willumsen L, Hole KH, Hompland T (2025)
Reduced field-of-view DWI outperforms conventional DWI in assessing tumor heterogeneity and HPV status in head and neck cancer
Sci Rep, 15 (1), 31889
DOI 10.1038/s41598-025-17284-8, PubMed 40883428

Mauthe M, van de Beek N, Mari M, Korsten G, Nobari P, Castelino KB, de Mattos EP, Ouhida I, Dijkstra JL, Schipper-Krom S, de la Ballina LR, Mueller MR, Simonsen A, Hipp MS, Kapitein LC, Kampinga HH, Reggiori F (2025)
A chaperone-proteasome-based fragmentation machinery is essential for aggrephagy
Nat Cell Biol (in press)
DOI 10.1038/s41556-025-01747-1, PubMed 40866512

More publications

Annual summary of publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)